JP Morgan Maintains Overweight on Astera Labs, Raises Price Target to $280

Benzinga Newsdesk www.benzinga.com Positive 77.8%

Neg 0% Neu 0% Pos 77.8%

JP Morgan analyst Harlan Sur maintains Astera Labs (NASDAQ:ALAB) with a Overweight and raises the price target from $205 to $280.